Title |
Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium
|
---|---|
Published in |
Journal of Circadian Rhythms, February 2007
|
DOI | 10.1186/1740-3391-5-3 |
Pubmed ID | |
Authors |
Sevag A Kaladchibachi, Brad Doble, Norman Anthopoulos, James R Woodgett, Armen S Manoukian |
Abstract |
Bipolar disorder (BPD) is a widespread condition characterized by recurring states of mania and depression. Lithium, a direct inhibitor of glycogen synthase kinase 3 (GSK3) activity, and a mainstay in BPD therapeutics, has been proposed to target GSK3 as a mechanism of mood stabilization. In addition to mood imbalances, patients with BPD often suffer from circadian disturbances. GSK3, an essential kinase with widespread roles in development, cell survival, and metabolism has been demonstrated to be an essential component of the Drosophila circadian clock. We sought to investigate the role of GSK3 in the mammalian clock mechanism, as a possible mediator of lithium's therapeutic effects. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 2% |
Germany | 1 | <1% |
Canada | 1 | <1% |
Argentina | 1 | <1% |
United States | 1 | <1% |
Unknown | 103 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 18 | 17% |
Student > Master | 17 | 16% |
Professor | 14 | 13% |
Researcher | 14 | 13% |
Student > Bachelor | 13 | 12% |
Other | 21 | 19% |
Unknown | 12 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 32 | 29% |
Medicine and Dentistry | 22 | 20% |
Neuroscience | 14 | 13% |
Biochemistry, Genetics and Molecular Biology | 7 | 6% |
Psychology | 4 | 4% |
Other | 10 | 9% |
Unknown | 20 | 18% |